Option Care Health downgraded to Hold from Buy at Jefferies
Jefferies downgraded Option Care Health (OPCH) to Hold from Buy with a new price target of $32.05, following an acquisition agreement at that price per share by CD&R and McKesson (MCK).
How this was made
The 30-second read
Why it matters
The downgrade may trigger short‑term selling pressure on OPCH, while the acquisition price sets a floor and could benefit McKesson's growth narrative.
Market read
The news provides a fresh catalyst for both OPCH and MCK, affecting short‑term price dynamics and sector M&A sentiment.
What to watch
Regulatory approval risk and integration challenges could delay value realization.
Background
Jefferies' downgrade coincides with the announcement of a cash acquisition of Option Care Health by CD&R and McKesson at $32.05 per share.
Ticker impact
Jefferies downgraded Option Care Health to Hold and set a new $32.05 price target as the company agreed to be acquired for $32.05 per share.
likely pressure as the market prices in the downgrade, with a floor near the $32.05 acquisition price
Analyst downgrade typically triggers sell‑offs; however, the cash‑out price from the deal provides a support level.
McKesson is named as a co‑buyer in the $32.05‑per‑share cash acquisition of Option Care Health.
potential modest upside as the deal expands McKesson's healthcare services portfolio
The acquisition adds a new revenue stream, but market reaction will depend on deal financing and integration expectations.
Market effects
Consolidation in the home‑health and pharmacy services sector may spur further M&A activity.
U.S. healthcare services market sees increased investor focus on acquisition-driven growth.
Limited to U.S. healthcare equities; no broader macro impact.
Counterpoint
The acquisition price may be too high, potentially overpaying for Option Care's assets.
Key entities
- companyOption Care Health
Home‑health services provider being acquired.
- companyMcKesson
Healthcare services distributor participating in the acquisition.
